State Street’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.24B | Sell |
|
|||||
|
2025
Q1 | $5.72B | Sell |
|
|||||
|
2024
Q4 | $4.82B | Buy |
|
|||||
|
2024
Q3 | $5.5B | Buy |
|
|||||
|
2024
Q2 | $5.5B | Sell |
|
|||||
|
2024
Q1 | $5.02B | Sell |
|
|||||
|
2023
Q4 | $4.92B | Buy |
|
|||||
|
2023
Q3 | $4.19B | Sell |
|
|||||
|
2023
Q2 | $4.34B | Buy |
|
|||||
|
2023
Q1 | $3.85B | Sell |
|
|||||
|
2022
Q4 | $3.57B | Buy |
|
|||||
|
2022
Q3 | $3.56B | Buy |
|
|||||
|
2022
Q2 | $3.46B | Buy |
|
|||||
|
2022
Q1 | $3.15B | Sell |
|
|||||
|
2021
Q4 | $2.71B | Buy |
|
|||||
|
2021
Q3 | $2.24B | Buy |
|
|||||
|
2021
Q2 | $2.36B | Buy |
|
|||||
|
2021
Q1 | $2.4B | Sell |
|
|||||
|
2020
Q4 | $2.7B | Buy |
|
|||||
|
2020
Q3 | $3.09B | Sell |
|
|||||
|
2020
Q2 | $3.39B | Buy |
|
|||||
|
2020
Q1 | $2.72B | Buy |
|
|||||
|
2019
Q4 | $2.49B | Buy |
|
|||||
|
2019
Q3 | $1.92B | Sell |
|
|||||
|
2019
Q2 | $2.09B | Sell |
|
|||||
|
2019
Q1 | $2.11B | Buy |
|
|||||
|
2018
Q4 | $1.8B | Sell |
|
|||||
|
2018
Q3 | $2.1B | Buy |
|
|||||
|
2018
Q2 | $1.78B | Buy |
|
|||||
|
2018
Q1 | $1.64B | Sell |
|
|||||
|
2017
Q4 | $1.64B | Sell |
|
|||||
|
2017
Q3 | $1.71B | Sell |
|
|||||
|
2017
Q2 | $1.46B | Sell |
|
|||||
|
2017
Q1 | $1.31B | Buy |
|
|||||
|
2016
Q4 | $867M | Buy |
|
|||||
|
2016
Q3 | $1,000M | Buy |
|
|||||
|
2016
Q2 | $845M | Buy |
|
|||||
|
2016
Q1 | $778M | Sell |
|
|||||
|
2015
Q4 | $1.23B | Buy |
|
|||||
|
2015
Q3 | $1.01B | Buy |
|
|||||
|
2015
Q2 | $1.19B | Sell |
|
|||||
|
2015
Q1 | $1.17B | Sell |
|
|||||
|
2014
Q4 | $1.22B | Buy |
|
|||||
|
2014
Q3 | $1.1B | Sell |
|
|||||
|
2014
Q2 | $943M | Sell |
|
|||||
|
2014
Q1 | $714M | Buy |
|
|||||
|
2013
Q4 | $716M | Buy |
|
|||||
|
2013
Q3 | $703M | Buy |
|
|||||
|
2013
Q2 | $565M | Buy |
|